Dudley Robert Michael 4
4 · Transcode Therapeutics, Inc. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2022-09-14$1.15/sh+20,000$23,000→ 893,114 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.1761, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.